Family's Bipolar Experience Inspires Monumental $1 Billion Research Donation
Jon Stanley considers himself fortunate among individuals living with bipolar disorder. After experiencing what he describes as "full-brained mania" nearly four decades ago—an episode that left him naked in a New York City deli, convinced electricity was coursing through the floor—he eventually found the right combination of medications. For many others, the journey to effective treatment remains significantly longer and more challenging.
The retired lawyer recalls being told during his treatment that severe mental healthcare was "more art than science" at that time, with doctors rotating through various medicines to "see if anything stuck." This difficult personal experience inspired his late parents, Ted and Vada Stanley, to donate hundreds of millions of dollars toward research into treatments for bipolar disorder and schizophrenia during their lifetimes.
Expanding a Philanthropic Legacy
Now, their philanthropic legacy continues with renewed vigor. Earlier this month, the Stanley Family Foundation announced an additional $280 million gift to the Stanley Center for Psychiatric Research at the Broad Institute. This substantial contribution brings their total donations to the Massachusetts-based nonprofit research organization to over $1 billion.
The dedication reflects both the family's belief in the institute's unique team-based approach and Jon's commitment to honoring his father's vision for applying the wealth accumulated through his successful collectibles retail business. "He said he wanted his 'Manhattan Project,'" Jon recalled of his billionaire father's ambitions. "And so, the only question was: who was gonna be Oppenheimer?"
The Broad Institute's Collaborative Approach
Launched in 2004 to tackle disease research through collaborative efforts, the Broad Institute combines faculty from MIT, Harvard, and other scientific institutions. It has attracted prominent philanthropists including founding donors Eli and Edythe Broad, as well as former Google CEO Eric Schmidt and his wife Wendy.
What makes the Stanleys' giving particularly remarkable is its almost exclusive focus on a single recipient—a staggering commitment to one research organization. This latest unanticipated gift will fund another seven years of work aimed at understanding how psychiatric illnesses develop.
According to Ben Neale, co-director of the Broad Institute's Stanley Center for Psychiatric Research, the goal is to leverage rapid advancements in DNA sequencing to accelerate new interventions. "We've made major discoveries of genes that dramatically increase the risk of developing these illnesses," Neale explained. "We know we only have a small fraction of what is out there to be discovered."
Personal Connection Drives Dedicated Support
Jon grew up along the Connecticut coast as his father's consumer products company, MBI, grew increasingly successful. "The money kept getting bigger," he noted, but his father informed him early on that he intended to give away most of the fortune.
A focused philanthropic outlet emerged when Jon developed bipolar disorder at age 19. His first manic episode occurred during a London educational program while attending Williams College. He harbored ambitious dreams of making millions by establishing student housing for Americans studying abroad, but quickly spent all his money while flipping between mania and depression.
The situation worsened upon his return to campus in Massachusetts. During a New York City visit, he frightened his girlfriend with comments about secret agents following him. After three days wandering Manhattan without money, he wound up in a deli where he experienced imagined electric shocks that caused his body to hurt. "So, I did the logical thing: I took my clothes off. And that's how the cops found me," Jon recounted.
He spent six weeks in a psychiatric hospital in 1987, occasionally confined to the "rubber room." Lithium, which he had already been prescribed, proved ineffective alone. The addition of an anticonvulsant called Tegretol finally provided relief. Neither drug was originally developed to treat bipolar disorder, and doctors lacked the genetic understanding of the disease that exists today—insights that have been significantly advanced by Broad Institute research.
Strategic Philanthropic Vision
Jon's parents were determined to change the landscape of mental health research, but his father didn't "just start writing checks everywhere." The family first founded the Stanley Medical Research Institute, but as Ted aged, he decided to concentrate nearly everything on the Broad Institute.
Frustrated with traditional academic research models where professors string together grants while working separately on similar causes, Ted Stanley wanted to consolidate resources. "We give all the money to Broad and they're all looking at the one problem," he explained. "It's much more like a wartime economy."
His father devoted $825 million altogether, but the stock market—where he had invested his philanthropic funds—performed better than expected, creating additional resources to commit. As one of three Stanley Family Foundation trustees, Jon held no reservations about the Broad Institute receiving even more support, considering it his obligation to do "what my dad would want if he was here."
"He didn't think he needed all that he made," Jon reflected. "But he was very interested in making more so he could give it away. So, who am I to overrule what he thought?"
The Broader Context of Medical Philanthropy
While funding to understand and treat mental illness might appear robust, experts caution that combined support from government, private industry, and philanthropy pales in comparison to the burden caused by diseases such as bipolar disorder.
The federal government provided more than $2 billion annually for mental health between 2019 and 2024. However, studies show schizophrenia alone costs the United States more than $300 billion yearly—partially due to fragmented care systems that fail to treat people proactively enough, according to Sylvie Raver, a senior director at the Milken Institute's Science Philanthropy Accelerator for Research and Collaboration.
Raver noted there has been a decline in support for serious mental illness at the National Institutes of Health, with existing funding often siloed and not necessarily targeted toward the needs of impacted families like the Stanleys. "When you marry capacity, like what the family has, and understanding and personal resonance with the topic, like they have as well, philanthropy is really primed to do exciting things," said Raver, who leads brain disease and mental health portfolios.
Pharmaceutical companies, another significant research funder, face obligations to generate profits for shareholders and bring products to market. Neale acknowledged that private industry's difficulty developing drugs for psychiatric conditions has chilled their enthusiasm in this area.
"These are some of the most difficult problems in all of medicine," Neale admitted. "We don't even understand where the fundamental pathology is, the thing that's giving rise to the illness."
Future Research Directions
Neale hopes nonprofit researchers can catalyze progress across the entire field. His goal for the next decade is to jumpstart clinical trials for schizophrenia and bipolar disorder interventions. "Anything less and we will have failed," he stated firmly.
His team will also recruit enough people with bipolar disorder who carry genetic variants to study whether their mutations have clinical significance. The more they demonstrate what's possible, Neale believes, the more participants they'll attract to their research efforts.
Jon, a founding board member of the nonprofit Treatment Advocacy Center, has been involved in mental health advocacy long enough that he tries not to become overly excited about any single breakthrough. His family's confidence in the Broad Institute stems not from its successes alone, but from its rigorous processes.
"It's not just shaking a test tube and seeing if it turns blue or red," Jon explained. "They'll notice things and analyze the data in a way that, even if it doesn't work, they'll learn something."
